Study links obesity to worse long-term MS disability
Key Takeaway
Genetic evidence linked higher body weight to worse long-term disability in people with MS.
What They Found
The researchers studied whether body weight was linked to MS disability. They used inherited genetic differences linked to body weight to help separate weight from other factors. Genetic evidence linked higher body weight to worse MS disability. Other measures of overall obesity supported this finding. Measures of where body fat is carried did not show the same link.
Who Should Care and Why
The disability study included people with MS. It focused on whether obesity was linked to how severe their MS became. The findings concern long-term disability, not a specific symptom. The study looked at overall obesity and where body fat is carried. Its findings may matter to people wondering whether body weight is linked to MS severity.
Important Considerations
The researchers studied 12,584 people with MS using genetic data, rather than testing a treatment. You cannot tell from this study whether losing weight would change MS disability. The abstract does not say which forms of MS the participants had.
AI-generated summary — for informational purposes only, not medical advice
Categories:
You May Also Like
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More
11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More
11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More
11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More
10/9/2026
A mouse study suggests prepared red blood cells may calm MS-like immune attacks. Learn why liver cel
Read More
10/9/2026
See how lab-grown nerve cells move a key protein, why this may matter for nerve health, and why the
Read MoreUnderstanding MS Research
Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.